Regarding the private placement, the offering was largely placed to begin with, however the process of getting the subscription agreements in, checking them for deficiencies etc has been much more drawn out than expected. All of the subscription agreements are now in place and under review by counsel. We are nearly there.
Regarding Alphamind, recall there were two products Iines, five mushroom blend capsule and powder. The powder has completed testing and the capsules are still out for testing. Next step is labelling and packaging, setting up fulfillment and building out the new AlphaMind website which are all underway.
Our last press release was dated July 14th, 2020 surrounding Q2, 2020 guidance on financial performance, followed by annual and interim filings.
I hope to announce the private placement closing in short order and disclosure of material events with the company will be ongoing.